Results 21 to 30 of about 201,990 (292)

Maintenance Therapy of Psychosis Spectrum Disorders in a Real-World Setting: Antipsychotics Prescription Patterns and Long-Term Benzodiazepine Use

Frontiers in Psychiatry, 2022
BackgroundMaintenance therapy of patients with primary psychosis spectrum disorders (PSD) in the Western Balkans has received limited interest so far.
Nadja P. Maric, Sanja Andric Petrovic, Manuela Russo, Stefan Jerotic, Ivan Ristic, Bojana Savić, Tamara Pemovska, Milos Milutinovic, Emina Ribic, Silvana Markovska-Simoska, Alma Dzubur Kulenovic, Nikolina Jovanovic   +11 more
doaj   +1 more source

Minimal-medication approaches to treating schizophrenia [PDF]

, 2009
UK guidelines for treating people diagnosed with schizo phrenia currently emphasise the primacy of antipsychotic medication, with or without psycho-socially based interventions as circumstances dictate.
Aderhold, Agar-Jacomb, Barnes, Bennett, Burston, Calton, Carpenter, Ciompi, Ciompi, Cooper, Davis, Day, Descartes, Digby, Fins, Fulford, Gray, Griesinger, Grisso, Harrow, Helen Spandler, Hogarty, Hyman, Loebel, Mosher, Mosher, Mosher, Pasamanick, Pincus, Podvoll, Porter, Pullen, Rappaport, Rose, Seikkula, Seikkula, Statsny, Tim Calton, Warner, Watkins, Wirt   +40 more
core   +1 more source

Recovery from psychosis : physical health, antipsychotic medication and the daily dilemmas for mental health nurses [PDF]

, 2015
This paper considers some of the dilemmas experienced by Mental Health Nurses everyday when faced with the seemingly conflicting relationships that exist between recovery, antipsychotics and the physical health of people experiencing psychosis.
Bressington, D., Bressington, Daniel, White, J., White, Jacquie   +3 more
core   +1 more source

Adjunctive antidepressive pharmacotherapy in schizophrenia patients

European Psychiatry, 2021
Depressive symptoms during long-term course of schizophrenia constitute an important and frequent clinical problem. They may occur either as stand-alone major depressive episodes (MDEs) or as part of the schizophrenic negative syndrome.
M. Zink
doaj   +1 more source

Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A meta-analysis of randomised controlled treatment trials [PDF]

, 2006
Small studies have shown positive effects from adding a variety of antipsychotic agents in patients with obsessive–compulsive disorder who are unresponsive to treatment with serotonin reuptake inhibitors. The evidence, however, is contradictory.
Carey, P, Denys, D, Fineberg, N, Premkumar, P, Seedat, S, Sivakumaran, T, Stein, DJ, Vythilingum, B, Westenberg, H   +8 more
core   +1 more source

Challenges in schizoaffetive disorder therapeutic – a case report of a patient with hiperprolactinemia

European Psychiatry, 2021
Introduction The only FDA approval therapeutic for schizoaffective disorder is paliperidone. Hiperprolactinemia is one of the most frequent side effects induced by first generation antipsychotics (FGA) or by second generation antipsychotic (SGA), such ...
D. Rodrigues, D. Jeremias, C. Laginhas, A. Sequeira   +3 more
doaj   +1 more source

Antipsychotics for irritability in children with Autism Spectrum Disorders

European Psychiatry, 2022
Introduction Autism is a neurodevelopmental disorder characterized by qualitative impairments in social interaction, communication, and restricted and repetitive behaviors [1]. Despite of these symptoms, some patients present different manifestations of
V. Muñoz Martinez, L. Beato-Fernández, E. Segura-Escobar   +2 more
doaj   +1 more source

Pancreatitis following Olanzapine Therapy: A Report of Three Cases [PDF]

, 2007
CONTEXT: Atypical antipsychotic agents (clozapine, olanzapine) have been linked to metabolic effects and acute pancreatitis. CASE REPORT: We reviewed the inpatient and outpatient records of three patients who developed acute pancreatitis while being ...
Azar, Riad, Jonnalagadda, Sreenivasa, Kerr, Thomas A., Prakash, Chandra   +3 more
core   +4 more sources

Pdxdc1 modulates prepulse inhibition of acoustic startle in the mouse. [PDF]

, 2017
Current antipsychotic medications used to treat schizophrenia all target the dopamine D2 receptor. Although these drugs have serious side effects and limited efficacy, no novel molecular targets for schizophrenia treatment have been successfully ...
Boutros, PC, Feldcamp, LA, Fletcher, PJ, Nobrega, JN, Raymond, R, Wong, AHC   +5 more
core   +1 more source

Metabotropic glutamate 2/3 receptors and epigenetic modifications in psychotic disorders: a review [PDF]

, 2016
Schizophrenia and Bipolar Disorder are chronic psychiatric disorders, both considered as "major psychosis"; they are thought to share some pathogenetic factors involving a dysfunctional gene x environment interaction.
Grayson, Danis R, Guidotti, Alessandro, MATRISCIANO, FRANCESCO, NICOLETTI, Ferdinando, PANACCIONE, ISABELLA   +4 more
core   +2 more sources